AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Rituxan (Genentech) (rituxan.com)
This is a high-integrity, substance-heavy pharmaceutical website that successfully prioritizes clinical accuracy and safety over marketing fluff. It is almost entirely devoid of traditional business bullshit, save for a few minor corporate power-phrases in the top-level headings.
To achieve a near-zero BS score, the site should include direct, clickable outbound links to published clinical trial data on PubMed or ClinicalTrials.gov. Adding a ‘Last Updated’ timestamp to each specific disease page would improve transparency for the 2026 temporal context. Specifically, the homepage H1 could be replaced with a more technical, product-focused headline to match the substance of the sub-pages. Finally, adding Person schema for the Chief Medical Officer or lead researchers would close the institutional authority gap.
Substance density is high, as the text consists largely of mandated clinical disclosures and specific diagnostic indications. While the H1 ‘COMMITTED TO CONNECTING YOU WITH YOUR TREATMENT’ is a standard corporate power-phrase, it is anchored by high-density technical data regarding Rheumatoid Arthritis (RA) and Pemphigus Vulgaris (PV). The ratio of specific nouns (e.g., ‘intravenous infusion’, ‘B-cell acute leukemia’) to fluff is highly favorable.
If your @id chain is broken, your entire knowledge graph collapses into isolated nodes. Check your AI visible entity graph with a free one page structured data interpretation.
There is no detectable semantic drift between the homepage signal and sub-page delivery. The homepage promises information for patients regarding six specific medical indications, and the sub-pages for NHL and CLL deliver exact details on treatment response, dosing, and safety for those specific populations. The messaging is consistently clinical and safety-oriented throughout.
Identify the current state and friction diagnosis of your specific business model. Generate your Executive SEO Strategy to quantify the financial or conversion cost of strategic misalignment.
The site does not engage in typical trust theatre like unverified testimonials or award badges. However, it loses minor points because while it references ‘Prescribing Information’ and the ‘Medication Guide,’ the crawled data shows a proof_links_count of 0, indicating a lack of direct outbound links to peer-reviewed clinical study results in the primary text blocks. This is a common but notable proof-path gap.
The proof-to-fluff ratio is excellent. For every claim of being an ‘FDA-approved treatment,’ the site provides a corresponding section on INDICATIONS and possible side effects. The data is highly specific, referencing ages (e.g., ‘children 6 months of age and older’) and specific combination therapies (e.g., ‘with glucocorticoids’).
To see how the system reconstructs a medical entity graph at scale, review the full Cleveland Clinic Structured Data audit. View the Cleveland Clinic Structured Data Audit for a live example of identity level decomposition and cross page entity mapping.
The site uses specific industry jargon like ‘FDA-approved’ and ‘CD20-positive B-cells’ which are functional rather than cliché. It avoids the value_prop_cliches identified in the dictionary, such as ‘innovation for life.’ The inclusion of a specific financial limit for support (‘$25,000 per calendar year’) further separates the value proposition from generic industry templates.
Authority is solidly established through the Genentech Organization schema and the prominent FDA adverse event reporting instructions. There are no unverifiable expert claims; the site relies on institutional authority rather than individual ‘expert’ personas. The technical implementation of heading hierarchy (H1 to H5) is structurally sound and meaningful.
The site’s marketing tone is exceptionally reserved, fitting for a regulated pharmaceutical product. Bold performance claims are replaced by moderated clinical statements such as ‘is thought to work’ and ‘to reduce the signs and symptoms.’ There is no disconnect between the promise of a medical treatment and the dense technical safety data provided to back it up.
Medical Devices, Pharma & Biotech BS: Rituxan (Genentech) (rituxan.com)
The content perfectly matches the Pharmaceutical and Biotech industry profile. It focuses entirely on a specific therapeutic antibody (rituximab), its mechanism of action on CD20-positive B-cells, and the regulatory indications for serious conditions like NHL and CLL.
Your site's meaning is determined by its graph, not its menus. Review the Internal Linking Architecture Framework to see how AI interprets nodes, edges, and authority flow inside your domain.
“The score of 13 is one of the lowest possible for a commercial site, driven by high Information Density and zero Semantic Coherence issues. The remaining points are derived from the lack of direct outbound evidence links and the minor presence of generic corporate phrasing in the hero sections.”
Analysis Disclosure & Source Attribution
Snapshot Date: June 19, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at Rituxan (Genentech) to view the most current version of their content and see directly what the company offers.